Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance SMR Q1 2026 Earnings EPS Miss Amid No Revenue Stock Rises Judge Blocks Trumps Kennedy Center Renaming Legal Precedent and Funding Implications